Xingfa Chem(SH:600141) Haitong Securities International·2025-04-10 07:11Investment Rating - Maintain 'Outperform' rating for the company, indicating expected performance above the market benchmark over the next 12-18 months [4][9]. Core Views - Despite challenges in glyphosate and silicone sectors, the company achieved stable growth in 2024, supported by its growth and resource sectors [4][9]. - The earnings forecasts for 2025-2026 have been lowered due to the lack of recovery in agrochemical and silicone sectors, with new forecasts for 2027 introduced [4][9]. - The target price is maintained at 24.34 RMB, corresponding to a PE ratio of 14.5x for 2025, which is above the average of 11.5x for comparable companies, reflecting optimism about the dual main business elasticity [4][9]. Financial Summary - 2024 revenue is projected at 28.40 billion RMB, a slight increase of 0.41% year-on-year, with net profit attributable to shareholders at 1.60 billion RMB, up 14.33% [4][9]. - The fourth quarter of 2024 saw revenue of 6.35 billion RMB, a year-on-year increase of 1.70%, but a quarter-on-quarter decrease of 26.60%, with net profit of 287 million RMB, down 35.82% year-on-year and down 43.63% quarter-on-quarter [4][9]. - The company plans to focus on phosphate expansion and downstream fine products capacity in 2025, aiming to complete several key projects within the year [4][9]. Financial Projections - EPS for 2025-2027 is projected to be 1.68, 1.93, and 2.19 RMB respectively, with previous estimates for 2025-2026 being 2.01 and 2.25 RMB [4][9]. - The company aims to complete various projects, including 40,000 tons/year ultra-high purity electronic chemicals and electronic-grade hydrogen peroxide expansion projects [4][9]. - Significant profit increases are expected from phosphate and specialty chemicals sectors, demonstrating resilience from deep industry chain cultivation [4][9].